Dr. Simpson is a pediatric hematologist/oncologist at CHEO and has been an assistant professor at the Department of Pediatrics at the University of Ottawa since August 2012. She received her medical degree from McGill University and completed her general pediatrics training and pediatric hematology/oncology fellowship at the Hospital for Sick Children and the University of Toronto. Dr. Simpson has additionally completed a Master’s in Public Health at the Johns Hopkins Bloomberg School of Public Health and was a trainee within the American Society of Hematology Clinical Research Training Institute (ASH CRTI).
As physician lead for the CHEO Sickle Cell Disease Program, she is a passionate mentor and educator and co-authored the 2014 Consensus Statement on the Care of Patients with Sickle Cell Disease in Canada for the Canadian Haemoglobinopathy Association. Dr. Simpson’s primary research interests relate to health systems improvement for children and adults with hemoglobinopathies and other chronic hematological conditions. She is Treasurer for the Canadian Haemoglobinopathy Association and a board member for the Black Physicians’ Association of Ontario. In 2017, she received an award for medical excellence from the Sickle Cell Awareness Group of Ontario and since 2018, she has been a research mentor for the American of Hematology Minority Medical Student Mentorship Program.
Increasing Incidence and Prevalence of Pathologic Hemoglobinopathies Among Children in Ontario, Canada from 1991-2013
Through an innovative approach using provincial health administrative, immigration and demographic data, this study identified a rising incidence and prevalence of hemoglobinopathies among Ontario children <18 years of age between April 1, 1991 and March 31, 2013, potentially due to increased immigration rates.
Exploring the Needs of Adolescents With Sickle Cell Disease to Inform a Digital Self-Management and Transitional Care Program: Qualitative Study
Adolescents, parents, and health care providers described the continued challenges youth with sickle cell disease face in terms of psychosocial impacts and stigmatization.